Powered by

-Poxel Announces Participation at Upcoming Virtual Investor Conferences in June

May 20, 2021 - ENP Newswire

LYON, France - POXEL SA (Euronext - POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH), today announced its participation at upcoming virtual investor conferences in June 2021. Thomas Kuhn, CEO, will present the company and Poxel management team members will be available for one-on-one virtual meetings.

Jefferies Global Healthcare Conference...